✦ LIBER ✦

Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010

✍ Scribed by Barut, Sener; Gunal, Ozgur; Erkorkmaz, Unal; Yildiz, Feyza

Book ID: 121977220
Publisher: SciELO
Year: 2012
Tongue: English
Weight: 143 KB
Volume: 16
Category: Article
ISSN: 1413-8670
DOI: 10.1016/j.bjid.2012.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implications of PNPLA3 polymorphism in c

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

✍ L. Valenti; A. Aghemo; A. F. Stättermayer; P. Maggioni; S. De Nicola; B. M. Mott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

The outcomes of glucose abnormalities in

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy

✍ Jee-Fu Huang; Ming-Lung Yu; Chung-Feng Huang; Suh-Hang Hank Juo; Chia-Yen Dai; M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

794 EFFICACY OF RIBAVIRIN PLUS PEGINTERF

794 EFFICACY OF RIBAVIRIN PLUS PEGINTERFERON-ALFA IN ELDERLY PATIENTS WITH CHRONIC HEPATITIS C

✍ T. Honda; Y. Katano; M. Doizaki; K. Hayashi; M. Ishigami; I. Nakano; F. Urano; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Treatment of insulin resistance with met

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

605 Hepatitis C virus (HCV)-specific T c

605 Hepatitis C virus (HCV)-specific T cell response in patients with chronic hepatitis C who received peginterferon (PEG-IFN) α-2a plus ribavirin

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Safety and efficacy of peginterferon plu

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

✍ F. Marrache; Y. Consigny; M. P. Ripault; D. Cazals-Hatem; M. Martinot; N. Boyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB